Transplantation

Article	Citations
236.8: Early Surgical Complications in Everolimus (EVR) Treated Renal Transplant Recipients	115
332.10: Pre-transplant Coronary Angiography Findings Based on Coronary or Aorto-Iliac Calcification on CT Imaging in Asymptomatic Patients With a Negative Cardiac Stress Test	92
416.5: Pregnancy-Induced Sensitization in Female Transplant Candidates: HLA-Specific Memory B Cells and Paternal HLA Epitope Mismatch	85
426.5: Regular Physical Activity in the Prevention of Post-transplant Diabetes Mellitus and Associated Metabolic Conditions in Kidney Transplant Recipients	84
216.14: Validating a Cut-off of IgG Hypogammaglobulinemia as a Risk Factor of Severe Infection in Solid Organ Transplantation	79
425.4: The Role of Role of Sex and T Cells in Natural vs Induced ABO Antibody Production in Mice	75
P8.112: Pregnancy Outcomes in Kidney Transplant Recipients And Their Newborns	72
P9.35: Application of CRL-Classification (J. Yan ET AL., 2020) Principles for Description of Rare Hepatic Artery Anomalies	69
247.9: Liver Transplantation from Discarded Liver Grafts. A Useful Policy for Expanding the Liver Donor Pool in Mexico	67
240.7: Macrophages and Different Subtypes Infiltrated in Kidney Allografts With Antibody-Mediated Rejection	63
210.10: Seroconversion After Vaccination With BNT162b2 Pfizer/BioNTech, ChAdOx1 nCoV-19/AZD1222 and Coronavac Against Sars-cov-2 Among Hemodialysis and Kidney Transplant Patients	61
310.8: OVID-Related Neonatal Cholestasis? Liver Transplantation in Three Infants With Perinatal COVID Exposure	61
414.3: Review of the Safety and Efficacy of Immunosuppression in the Pig-To-Nonhuman Primate Islet Xenotransplantation Model	60
P2.11: Distinct Global DNA Methylation and NF-κB Expression Profile of Preimplantation Biopsies From Ideal and Non-ideal Kidneys	60
410.5: The Impact of COVID-19 on Renal Function of Kidney Transplant Recipients: A Three-Month Prospective Study	56
313.5: Meeting Packed Red Blood Cell Requirement for the Transmedics Organ Care System (OCS) Liver Transplantation Trial (PROTECT Trial) At Henry Ford Hospital	53
340.11: Flow Cytometric Pattern of Gamma Delta TCR Expression Identifies Outcomes in Kidney Transplantation	50
P8.067: Catastrophic EBV Infection After Cadaveric Kidney Transplantation	49
P8.142: Perturbations in Podocyte Transcriptome and Biological Pathways Induced by Injury Caused by FSGS Associated Circulating Factors	46
P10.03: Alternative Surgical Techniques for Abdominal Wall Graft Donation to Guarantee Abdominal Wall Closure in the Donor	46
P11.38: Impact of Two Different TV Content on Promote Organ Donor Registration	43
316.7: ABO – Incompatible Kidney Transplantation in COVID 19 Era: A Single Centre Experience	41
P17.07: Comparison of Graft Survival Between Full Thickness And Lamellar Pig-To-Monkey Corneal Xenotransplantation From the Same Genetically Engineered Pig With Minimal Immunosuppression	41
P5.01: Belt & Road Organ Donation Capacity Improvement Cooperation Training Project (BROAOD)	41
P8.027: Idiopathic Polymyositis in Renal Transplant Recipient: Case Report and Review of Literature	39

414.10: Cytokine Analysis of First Gal-KO Renal Xenotransplantation From a Pig-To-Human Recipient	37
P9.40: Liver Transplantation for Secondary Hemophagocytic Lymphohistiocytosis Associated Acute Liver Failure: A Case Report	36
P11.30: Influence of Basic Cardiopulmonary Reanimation on Uncontrolled Donors After Cardiac Death	36
245.8: Effect of CYP3A5 Genotype-Guided Versus Conventional Initial Dose of Tacrolimus in Children With Kidney Transplants	35
364.1: Survival benefit of living donor availability for pediatric liver transplantation in a large North American center: An intention-to-treat analysis.	35
313.2: Solitary Pancreas Transplantation - Significant Improvement over the 2 last Decades	35
32: 30-year experience of children with Intestinal Failure Associated liver disease	34
ILTS 2022 Joint International Congress of ILTS, ELITA & LICAGE, May 4-7, 2022	34
328.2: A bioengineered artificial interstitium supports long-term survival of therapeutic xenogeneic porcine islet cells in nonhuman primates without immunosuppression	33
217.6: Beneficial effects of transgenic expression of human CD200 on top of quadruple-knockout/double-knockin (CD46/thrombomodulin) pigs on kidney xenograft survival in nonhuman primates	33
237.2: Synergistic inhibition of human NK cell activation by co-expression of HLA-E and HLA-G on porcine endothelial cells	33
313.1: A novel risk factor for immediate pancreas graft failure: hypertension in the donor	33
236.3: Improved outcomes following simultaneous pancreas-kidney transplantation in the second decade of the new millennium: a single center longitudinal analysis by era	32
P.13: Effect of human amniotic epithelial cells on intraportal islet transplantation	32
P.333: Interferon-gamma release test results in organ transplant recipients and donors at Başkent University Faculty of Medicine Hospital.	31
236.4: Early differences in glucose homeostasis between diabetes type 1 versus type 2 recipients of kidney/pancreas transplants	31
P.345: Biliary sludge and complications in multivisceral transplantation patients.	30
P4.5: Red cell distribution width (RDW): A prognosis indicator of brain death in patients with GCS<6	30
366.1: iRhom2 regulates hepatocyte senescence in ischemia/reperfusion injury by modulating HMGB1 secretion.	30
P.425: Kidney donation and kidney transplantation among Ukrainians in Poland within two years of war in Ukraine.	30
116.5: Empowering organ donation advocates through online grass-root level volunteer training: ‘the organ donation ambassadors program’	29
123.7: How to increase organ and tissue donation with a low budget and better approach	29
P8.6: A historical review of heart transplantation in Saudi Arabia: trends, progress, and heart valve utilization	29
P.506: Outcome of heart transplant in a young patient referred with cardiogenic shock and multi-organ failure.	28
P1.1: Laryngotracheal transplant: Patient and caregivers’ beliefs and perceptions	28
322.4: Engineering pancreatic islet grafts with innate immune modulators to mitigate instant blood-mediated inflammatory reaction.	27
P.493: Utilization of mechanical assist devices in pediatric patients with end-stage heart failure.	27
P.488: Pediatric liver transplantation in Situs inversus and other vascular abnormalities.	27
403.3: Beyond kidney donation: Unveiling predictors of long-term kidney function in living donors.	27
P.303: An exploratory study of patient-provider communication during the medical evaluation for kidney transplantation.	27
P.370: Correction of portal vein stenosis in patients following living donor liver transplantation.	27
247.11: Comparative assessment of steatotic livers in preservation solutions: New compositions for old problems.	26
P.086: Endoplasmic reticulum stress in recipient spleen follicular B lymphocytes in transplantation may affect the alloimmune response of T lymphoctes.	26
P.044: Rhabdomyolysis after cooked local fish consumption (Haff Disease) in kidney transplant in South of Brazil - Case report.	26
P.197: Patient’s death with a functioning graft (DWF) from infection is a major cause of renal transplant loss – A retrospective study from a single center.	26
247.5: Mitochondrial flavin mononucleotide measured at beginning of hypothermic machine perfusion predicts patient survival after liver transplantation.	26
V-210.3: Paired kidney exchange program: A utilitarian service to the underserved populations in the northern great plains of the United States.	26
320.12: The outcomes of renal transplantation in congenital chloride diarrhea- A cases series.	26
440.2: Clinical study of the importance of IgG level in kidney transplant recipient.	25
300.4: First experience of extracorporeal-cardiopulmonary resuscitation program and its impact in kidney transplant.	25
410.4: A prospective observational study to assess the role of donor derived cell free DNA (dd-cfDNA) in predicting active rejection in renal allograft recipients.	25
410.3: Anti-MICA antibodies and graft outcomes in kidney transplant recipients.	25
P.240: Advanced chronic kidney disease in kidney transplant recipients: A national cross-sectional cohort study.	24
264.9: GSK3β deficiency ameliorates hepatic ischemia-reperfusion injury by regulating necroptosis of kupffer cells.	24
Bile Chemistry During Ex Situ Normothermic Liver Perfusion Does Not Always Predict Cholangiopathy	24
Allogeneic Hematopoietic Stem Cell Transplantation in Elderly Patients: The Experience of the Grupo Español de Trasplante Hematopoyético y Terapia Celular	24
Patient and Provider Gender and Kidney Transplant Referral in Canada: A Survey of Canadian Healthcare Providers	23
Response to Letter: Global Immune Biomarkers and Donor Serostatus Can Predict Cytomegalovirus Infection Within Seropositive Lung Transplant Recipients	23
Alloreactive Tissue-resident Memory T Cells in Solid Organ Transplantation: Do They Light the Fire?	23
Liver Retransplantation Using Living Donor Grafts: A Feasible Approach for Chronic Allograft Failure	23

P12.15: Dapagliflozin for the Treatment of Post-transplant Diabetes Mellitus After Pancreas Transplantation: A Case Report With A 14-Month Follow-up	23
Unraveling Molecular and Functional Responses Across 3 Lung Injury Models to Expand the Donor Lung Pool	22
Highlights From Controversies in Transplantation 2023 Conference	22
Outcomes of Coccidioides Seropositive Solid Organ Transplant Recipients After Self-discontinuation of Antifungal Prophylaxis: The EIA-IgM-only Conundrum	22
Senotherapy: Implications for Transplantation	22
Beyond Adaptive Alloreactivity: Contribution of Innate B Cells to Allograft Inflammation and Rejection	22
New Allocation Systems: Principles and Processes (Pro)	21
From 6-wk Lungs to 6 y: Increasing the Donor Pool for Pediatric Lung Transplantation	21
Progress Update on the Transplant Surgery Training Pipeline in the United States	21
Research Highlights	21
405.2: Kidney transplantation in patients with intellectual disability.	21
CXCR5+CD8+ T Cell–mediated Suppression of Humoral Alloimmunity and AMR in Mice Is Optimized With mTOR and Impaired With Calcineurin Inhibition	21
Dysbiosis of the Female Murine Gut Microbiome Exacerbates Neutrophil-mediated Vascular Allograft Injury by Affecting Immunoregulation by Acetate	21
The Case for Prolonged ECMO for COVID-19 ARDS as a Bridge to Recovery or Lung Transplantation	21
Back to Basics: Liver Graft Ischemia in the Era of Machine Perfusion	20
Donor-derived Cell-free DNA and Acute Kidney Rejection: A Golden Opportunity or a False Hope?	20
Renal Transplantation in the Dominican Republic: Achievements, Challenges, and Gender Disparities	20
Minimizing Metabolic and Cardiac Risk Factors to Maximize Outcomes After Liver Transplantation	20
“Digital Tomosynthesis” As a Technique for the Evaluation of Endobronchial Stents in Lung Transplant Recipients	20
Never Say Never: The Latest Immune Rejection Ever Reported 51 y After Corneal Transplantation	20
Research Highlights	20
IL-35 Therapy Boosts Treg in Transplantation	19
Integrative Analysis of Prognostic Biomarkers for Acute Rejection in Kidney Transplant Recipients: Erratum	19
06-8: ISOLATION, CHARACTERIZATION AND DISTRIBUTION OF HUMAN PANCREATIC ISLETS FOR RESEARCH	19
47: 10 Years’ Experience of Transplant Oncology in the Management of Unresectable Desmoid Tumor: One-staged or Two-staged Approach	19
Amplified Natural Killer Cell Activity and Attenuated Regulatory T-cell Function Are Determinants for Corneal Alloimmunity in Very Young Mice	19
Dynamics of Humoral and Cellular Responses in Renal Transplant Recipients Receiving 3 Doses of SARS-CoV-2 mRNA Vaccine	19
What Can the Developing World (and Others) Learn From the Indian Experience in Crossing the ABO Blood Group Barrier in Kidney Transplantation	19
P-16: USING A TRANSIENT COLD ROOM DURING COBE ISLET PURIFICATION REDUCES THE ENVIRONMENTAL MICROBIAL BURDEN AND ASSOCIATED ENERGY COSTS WHEN COMPARED TO THE USE OF A PERMANENT COLD ROOM	19
The Challenges of Risk Aversion in Kidney Transplantation: Lessons From the SARS-CoV-2 Pandemic in Brazil	19
Research Highlights	19
P3.05: Apraglutide Decreases Severity of Intestinal Damage From Acute Gastrointestinal Graft Versus Host Disease (GI-GvHD) Following Allogeneic Transplantation Without Impacting Engraftment	19
01-8: HEPARIN THROMBOPROPHYLAXIS AFTER PANCREAS TRANSPLANTATION IMPROVES OUTCOMES: A SINGLE-CENTER EXPERIENCE	19
14-4: INVESTIGATING THE SUBCUTANEOUS SPACE AS AN ALTERNATIVE TRANSPLANT SITE FOR ISLET TRANSPLANTATION	19
Home-based LIver FrailTy Intervention (LIFT) in Transplant Candidates: A Feasibility Study	19
Cold Storage Disrupts the Proteome and Phosphoproteome Landscape in Rat Kidney Transplants	18
Insight Into Current BK Polyomavirus Research Efforts: BK Day Meeting 2024	18
Psychometric Properties of the BAASIS: A Meta-analysis of Individual Participant Data	18
Outcomes of Solid Organ Transplant Recipients Treated With Antispike Monoclonal Antibodies for Coronavirus Disease 2019 Across Variant Epochs: Impact of Comorbidities and Vaccination	18
Vaccination for HAV: A Lesson From Acute Hepatitis A Superinfection on Chronic B Hepatitis With Lifesaving Living Donor Liver Transplantation for Hepatic Failure	18
18. Lessons learned in sentinel skin flap vascularised composite allotransplantation through patient and public involvement	18
Chimerism-based Tolerance Induction in Clinical Transplantation: Its Foundations and Mechanisms	18
Deceased Donor Liver Procurement and Preservation Techniques: What is Cost-effective? A Systematic Review	18
Determinants of Immune Response to Anti–SARS-CoV-2 mRNA Vaccines in Kidney Transplant Recipients: A Prospective Cohort Study	18
Innate-like B Cells: Local Drivers of Non-HLA Immunity in Rejecting Kidney Allografts?	18
337.5: Islet transplantation versus insulin alone in type 1 diabetic kidney transplant recipients: a French nationwide study on behalf of the TREPID group	18
PS13.5: First-in-human trial of the treatment with human embryonic stem (ES) cell-derived hepatocyte-like cells for infantile urea cycle disorders.	18
Improved Waitlist Outcomes in Liver Transplant Patients With Mid-MELD-Na Scores Listed in Centers Receptive to Use of Organs Donated After Circulatory Death	18
Rethinking Priority for Prodonation Behaviors in Organ Allocation—Lessons From the Israeli Experience	18
16: RNA Sequencing (RNA-seq) Analysis Provides for Gene Signatures Specific to Intestinal Transplant Rejection	17
261.13: The setup used for ex vivo renal normothermic perfusion influences a kidney’s behavior on the pump.	17
Chronic Rejection After Kidney Transplantation	17
Can We Use Eplets (or Molecular) Mismatch Load Analysis to Improve Organ Allocation? The Hope and the Hype	17
323.5: The value of anonymous contact.	17
Prediction and Management of Small-for-size Syndrome in Living Donor Liver Transplantation: Methodology of the ILTS-iLDLT-LTSI Consensus Conference	17
Meeting Report: The Sixth International Sam Strober Workshop on Clinical Immune Tolerance	17
261.12: Novel system for organ preservation: Feed macrophages Ceria nanoparticles.	17
P.041: Switching from ciclosporin to tacrolimus as de novo calcineurin inhibitor in lung transplantation: First results of a multidisciplinary quality assurance project.	17
The Clinical and Economic Benefit of CMV Matching in Kidney Transplant: A Decision Analysis	17
308.5: IDEA: Development of the first decisional support tool for black American potential living kidney donors contemplating APOL1 genetic testing.	17
Prognostic Value of Chest CT Findings at BOS Diagnosis in Lung Transplant Recipients	17
113: Complications of vascular Ehlers-Danlos Syndrome: Management by an Intestinal Failure Multidisciplinary Team	17
264.4: Macrophage SETDB1 reduces inflammatory macrophage infiltration by inhibiting P2rx7 expression and alleviates liver ischemia-reperfusion injury.	17
320.15: Recurrence of focal segmental glomerulosclerosis among kidney transplant recipients: Kuwait experience.	17
107.1: Digital solutions and collaboration between authority and healthcare professions – The winning key to develop and implement guidelines at a national level?	17
216.7: Uniquely Tasmanian – Learnings from our island state.	17
Using Regression Equations to Enhance Interpretation of Histology Lesions of Kidney Transplant Rejection	17
P.175: Correlation of early graft dysfunction and baseline doppler ultrasound result.	16
P.357: The effects of early postoperative thrombocytopenia at intensive care unit admission to allograft function and outcomes after liver transplantation.	16
343.3: Up-regulated LRRN2 expression is effective as a marker for graft quality in living donor liver transplantation.	16
317.9: Report of a Case of Double Arm Transplantation Including Left Shoulder Reconstruction	16
P.100: Are transfusion reactions associated with hematopoietic stem cell product infusion more frequent than previously thought?	16
P.464: Social and structural disparity in possible organ donor discards in Chile.	16
P.178: Immunologic risk stratification of kidney transplant recipients by combining HLA-eplet MM and PIRCHE-II.	16
P8.020: Incidence and Correlates of Testicular Pain After Kidney Donation	16
P.077: Engineered mesenchymal stem cell-mediated release of the chemokine CCL28 remodels the immune microenvironment to resist graft rejection.	16
245.8: Shiraz Transplant Center; leader of the intestinal transplant in the Middle East; challenges and opportunities.	16
344.7: Predictive analysis of new-onset diabetes after kidney transplantation: Integrating clinical and radiological factors at Mayo Clinic.	16
241.9: Evaluation of renal allograft biopsy results and long-term allograft survival in kidney transplant recipients: Baskent University experience.	16
P15.10: The Impact of Different Induction Immunosuppression Protocol on Patient Survival, Graft Survival and Acute Graft Rejection After Kidney Transplantation – Multicenter Study	16

P8.052: Long-term Outcomes and Predictors of Graft Function in Living-Donor Preemptive Kidney Transplants	15
213.4: Single-dose Rituximab Induction May Prevent EBV Viremia in Paediatric Kidney Recipients Long-term: An Investigation From the Nordic Paediatric Renal Transplantatioinn Study Group	15
343.10: A Novel Approach for Pancreas Transplant With Arterial Patch	15
P9.10: Mono-Maintenance Therapy With Anti-icam-1 Monoclonal Antibody Induced Long-term Liver Allograft Survival in Nonhuman Primates	15
421.5: Extracorporeal Membrane Oxygenation Use in Orthotopic Liver Transplantation as a Viable Bridge to Transplant and Tool For Intraoperative and Postoperative Rescue	15
210.12: Booster Shots and Additional Doses for COVID-19 in Solid Organ Recipients	15
P8.086: Persistent Hyperparathyroidism Post Renal Transplantation	15
P14.07: Use of Grafts With Extended Ischemic Time (Above 4 Hours Or More): Analysis of the Experience of the Largest Brazilian Heart Transplant Center, From 2013 to 2022	15
242.7: Influence of CYP3A5 Polymorphisms on Tacrolimus Dosing in Renal Transplant Recipients	15
P8.135: Machine Learning in Kidney Transplantation: A New Possibility For the Graft Survival Prediction	15
P8.099: Post-operative Myocardial Infarction After Renal Transplant: Setback or Disaster?	15
P12.11: Immunomodulatory Microporous Annealed Particle (MAP) Gel Protects Delivery of Islets to Promote Islet Transplantation Outcomes	15
235.2: Prediction of Acute Rejection Post-kidney Transplant: An Artificial Intelligence Approach	15
241.1: Maturation and Evaluation of 3D Printed Bionic Pancreas With a Dedicated Bioreactor	15
317.1: Personalized Approach to Risk-Stratified Desensitization in Modified Multivisceral Transplantation	15
241.2: A Worldwide Survey of Activities and Practices in Clinical Islet of Langerhans Transplantation	15
P3.02: Assessment of Chimerism Testing by Next Generation Sequencing	15
211.8: Impact of Sarcopenia Using Anterior Thigh Skeletal Muscle Index on Clinical Outcomes in the Liver Transplant Recipient	14
416.1: Impact of HLA-A,B DR and DQ on Deceased Kidney Transplant Outcomes in the Tacrolimus/MMF Era: An Artificial Intelligence Approach	14
412.3: The Performance of the Kidney Donor Profile Index in Predicting Outcomes for Brazilian Kidney Transplant Recipients of Standard Criteria Donors	14
247.6: Preliminary Results of Ex-vivo Normothermic Machine Perfusion in Deceased Donor Renal Allograft Transplantation – First Clinical Experience From Asia	14
120.4: Preventable harm in the Canadian organ donation and transplantation system (semi colon) a descriptive study of missed organ donor identification and referral	14
211.3: Donor prostate cancer should not be contraindication for donation of kidney	14
243.9: Equality and Equity in Transplant for Children	14
400.1: The “Global Kidney Exchange” Proposal Is Impractical And Not Financially Neutral	14
312.1: Implementation of Longitudinal Portoplasty for Hypoplasic Portal Veins in Children With Biliary Atresia in a Liver Transplantation Centre in Argentina	14
106.5: Comparison of open surgery and ultrasound-guided percutaneous injection on the cytokine response to pig islet xenotransplantation	14
123.8: Spotlight on relatives of tissue donors - what factors influence the decision-making process?	14
P9.5: Organ donation between personal and cultural beliefs in Saudi Arabia	14
246.8: In Vivo Monitoring of Liver Organoids Differentiation Using Live-Screening-Optical Technologies	14
216.4: Wide Spectrum of Molecular Injury Highlights Heterogeneity of Banff Tubulitis and Interstitial Inflammation Lesions	14
334.3: Presentation of FasL Protein by PEG Microgels Within Graft Site Leads to Survival of Pancreatic Islets in Nonhuman Primates Without the Need for Chronic Immunosuppression	14
411.5: Autophagy Mediates Liver Functional Recovery From Donation After Circulatory Death Rats With Normothermic Machine Perfusion	14
246.2: Novel Avenue of Allograft Monitoring: Direct Measurement of Donor-Derived Extracellular Vesicles in Human Plasma	14
317.1: Perceptions and potential barriers of personnel involved in xenotransplant research	14
P3.3: Consider the causes of low organ donation in Japan by the GCS3 registry	14
122.6: Increasing kidney utilization	14
Replacing the Endomyocardial Biopsy: Easier Said Than Done	13
Invited Response to Letter to the Editor by Callaghan et al, “Following the Flow: Changes in Organ Preservation Methods Require Changes in Our Data Collection”	13
105.2: Novel subcutaneous islet transplantation method using a bioabsorbable medical device to facilitate the guidance of the highly vascularized transplantation site	13
337.4: Islet-alone vs. islet-after-kidney transplantation glycemic outcomes: Report from the Collaborative Islet Transplant Registry	13
117.6: Can pyelonephritis initiate antibody-mediated rejection (AMR) of a pig xenograft?	13
Pathophysiological Changes in the Hemostatic System and Antithrombotic Management in Kidney Transplant Recipients	13
Personality Traits in Patients With Cirrhosis Are Different From Those of the General Population and Impact Likelihood of Liver Transplantation	13
210.6: Development and dissemination of a unique virtual reality training program to improve physician skill, knowledge and confidence in determining brain death and family communication	13
118.8: Understanding pancreas-machine interactions during preservation: A mathematical approach	13
237.4: Evaluation of immune reactions in multi-knockout kidneys after perfusion with human blood	13
236.2: Simultaneous kidney-pancreas transplantation improves endothelial dysfunction induced by extracellular vesicles	13
336.5: Modifying The Porcine Genome for Xeno-organ Transplantation	13
Deceased Organ Donation and Transplantation in the United Arab Emirates: A View 7 y After Implementation	13
Amelioration of Diabetes and Neuropathy After Pancreas Transplantation: Measurable Differences in Vibration Perception Thresholds Impact Outcomes	13
The Relative Roles of Inflammation in Kidney Allotransplantation and Xenotransplantation	13
229.7: The role of sex hormones in the intestinal injury after brain death using a surgical menopause model in rats.	13
328.5: Islet encapsulation preserves their functionality following transplantation into immunocompetent diabetic animals without immunosuppression	13
121.5: The development progress of “the Shanxi Model”: the first independent provincial OPO in China	13
204.5: Pediatric kidney transplantation in the Middle East: Challenges and solutions.	13
Commentary on “Infection Risk in the First Year After ABO-incompatible Kidney Transplantation: A Nationwide Prospective Cohort Study”	13
AI-enhanced Information Navigation: Insights From Information Theory in Transplantation Data	12
344.3: An Inconvenient Offer: A Single OPOs Experience in Kidney Utilization.	12
The Cost-effectiveness of Transplanting Hearts From Hepatitis C-infected Donors Into Uninfected Recipients	12
The Mycophenolate-based Immunosuppressive Regimen Is Associated With Increased Mortality in Kidney Transplant Patients With COVID-19	12
IL-35 Stabilizes Treg Phenotype to Protect Cardiac Allografts in Mice	12
The Nuances of Hand Transplantation After Sepsis	12
Utility of OPO Procurement Surgeons in Reducing Discards of Marginal Liver Allografts	12
A Prevascularized Sinus Tract on the Liver Surface for Islet Transplantation	12
Finding the Road to Rome in Cardiac Allograft Vasculopathy Imaging Surveillance	12
ABO Antibody Development, a New Look at a Very Old Question	12
An Intention-to-treat View of Lung Transplantation for Interstitial Lung Disease: Successful Strategies to Minimize Waiting List and Posttransplant Mortality	12
Inflammation in Kidney Transplantation: Could Xenotransplantation Offer Greater Benefit?	12
C-peptide Targets and Patient-centered Outcomes of Relevance to Cellular Transplantation for Diabetes	12
Diagnostic and Therapeutic Implications of Ex Vivo Lung Perfusion in Lung Transplantation: Potential Benefits and Inherent Limitations	12
16-5: SOCIAL DETERMINANTS IMPACT PANCREAS TRANSPLANT LISTING, TIMING AND OUTCOME	12
313.12: Hypothermic Oxygenated Machine Perfusion of an En-Bloc Dual Kidney Specimen: Proof of Concept, in an Animal DCD Model, of a New Option to Preserve and Evaluate Kidney Grafts	12
Muhammad M. Mohiuddin, MBBS (MD), DSc (Hon)	12
MHC Tetramers Specifically Identify High- and Low-avidity Donor-specific B Cells in Transplantation Tolerance and Rejection	12
228.8: Artificial pancreatic islets produced by 3D bioprinting ink-jet technology with extracellular matrix as an environment for stem-cell derived beta cells.	12
CCL22-expressing Stem Cell–derived Islet Grafts Recruit Regulatory T Cells in Mice	12
Desensitization in Crossmatch-positive Kidney Transplant Candidates	12
Imlifidase Desensitization in HLA-incompatible Kidney Transplantation: Finding the Sweet Spot	12
Immune Monitoring Assays: Predicting Cytomegalovirus and Other Infections in Solid Organ Transplant Recipients	12
Identification of Differentially Expressed Genes in Cold Storage–associated Kidney Transplantation	12
Long-term Comparison of Everolimus and Mycophenolate in Tacrolimus-based and Steroid-free Immunosuppressive Regimen	12
Mitigating Health Disparities in Transplantation Requires Equity, Not Equality	11
Organ Transplantation in India: NOT for the Common Good	11
P.47: Impact of early versus delayed tacrolimus initiation on clinical outcomes in deceased donor kidney transplantation with thymoglobulin induction: Implications for graft allocation.	11
305.1: Non-retrieval and non-utilisation of deceased donor kidneys for transplantation: and Australian cohort study.	11
Use of Federal Reimbursement for Living Donor Costs by Racial and Ethnic Minorities: Implications for Disparities in Access to Living Donor Transplantation	11
211.4: D-Amino acids-based estimation of glomerular filtration rate is possible using the same formula in both children and adults.	11
210.6: Nepal: Learning from the decreased organ donation system in the United States of America to save more lives from organ transplantation.	11
320.1: Successful use of organs from donors with severe burns.	11
Three-dimensional Vascularized β-cell Spheroid Tissue Derived From Human Induced Pluripotent Stem Cells for Subcutaneous Islet Transplantation in a Mouse Model of Type 1 Diabetes	11
108.1: Optimizing organ donation in medico legal cases a retrospective review from the National Center for Regulating Donation and Transplantation of Human Organs and Tissues in the United Arab Emirat	11
405.4: Outcomes of kidney transplantation from uncontrolled donation after circulatory death. A retrospective study of Botkin Hospital.	11
306.5: From hospice to hope: The DCD pathway to life-saving donations.	11
217.4: Clinical risk aversion of potential deceased kidney donors forgone for biovigilance concerns: A data-linkage study.	11